Ohashi Ken
Nihon Rinsho. 2015 Dec;73(12):2141-7.
Diabetes mellitus is a frequent comorbidity of cancer patients. Recent data show that diabetes may negatively impact both cancer risks and outcomes of treatment. It is important to identify patients at risk for complications that arise from cancer treatment in the setting of pre-existing diabetes. Additionally, underlying hyperglycemia or hidden diabetes in a patient undergoing cancer treatment such as chemotherapy including steroid administration and total parenteral nutrition should be identified and managed. Strategies for monitoring and managing hyperglycemia during the course of cancer treatment will be reviewed. The role of interdisciplinary care and empowerment approach is crucial to supporting patients and their families as they manage through the challenges of facing two life-threatening diseases.
糖尿病是癌症患者常见的合并症。近期数据表明，糖尿病可能对癌症风险和治疗结果产生负面影响。识别在已有糖尿病背景下有癌症治疗相关并发症风险的患者很重要。此外，对于正在接受癌症治疗（如化疗，包括使用类固醇和全胃肠外营养）的患者，应识别并处理潜在的高血糖或隐匿性糖尿病。本文将综述癌症治疗过程中监测和管理高血糖的策略。跨学科护理和赋权方法在支持患者及其家人应对面临两种危及生命疾病的挑战时起着至关重要的作用。
